A 12-year-old girl is receiving treatment for malaria after recently returning from a trip to Africa, according to multiple reports from Italy. The case highlights the ongoing risk of imported malaria, even in regions where the disease is not endemic, and underscores the importance of preventative measures for travelers.
The girl was initially hospitalized in Chioggia, Italy, before being transferred to a hospital in Padua for further care. Details regarding her current condition have not been released, but reports indicate she is responding to treatment.
Imported malaria cases are relatively uncommon in Italy, but pose a particular threat to travelers, especially those visiting friends and relatives (VFR). A study examining cases from 2005 to 2015 found that Plasmodium falciparum was responsible for over 90% of imported malaria cases, with the vast majority contracted in Africa. The research, published in PubMed, also revealed that children are at a significantly higher risk of developing severe malaria compared to adults.
Researchers at the University of Padua are actively involved in efforts to combat malaria, including exploring innovative approaches like CRISPR-mediated gene drive technology. This research, led by Andrea Crisanti, Director of the Department of Molecular Medicine at the University of Padua, aims to disrupt the transmission of the disease.
The study from 2005-2015 also noted that chemoprophylaxis – the apply of preventative medication – was not widely adopted by travelers. Experts recommend that individuals traveling to malaria-endemic regions consult with their healthcare providers about appropriate preventative measures and adhere to recommended treatment protocols. Organizations like Doctors with Africa CUAMM and Penta are working to improve healthcare access and research capacity in Sub-Saharan Africa, focusing on infectious diseases like malaria, as detailed on their website.
The recent case serves as a reminder of the potential health risks associated with international travel and the demand for continued vigilance in preventing and treating infectious diseases.
